Avenue Therapeutics, Inc. Liquidation Value
ATXI
Other
Cash & Equivalents
$2.85M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $2.85M
Total Obligations: -$1.10M
$1.76M
Per share: $0.55
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $2.85M
AR: $0
Total Obligations: -$1.10M
$1.76M
Per share: $0.55
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $2.85M
AR: $0
Inventory: $0
Total Obligations: -$1.10M
$1.76M
Per share: $0.55
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $1.76M | $0.55 |
| Liquid Liquidation Value | $1.76M | $0.55 |
| Operating Liquidation Value | $1.76M | $0.55 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $2.85M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $1.10M |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 3.2M |
Explore all 90 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $2.85M | N/A | N/A | N/A | $1.10M | N/A | N/A | N/A |
| 2025-09-30 | $3.71M | N/A | N/A | N/A | $1.42M | N/A | N/A | N/A |
| 2025-06-30 | $3.33M | N/A | N/A | N/A | $1.33M | N/A | N/A | N/A |
| 2025-03-31 | $3.50M | N/A | N/A | N/A | $1.26M | N/A | N/A | N/A |
▼ Community Notes